Role of p90 Ribosomal S6 Kinase–Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.578278PMID 16585392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation.

  2005cited by this paper
• The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.

  2005cited by this paper
• Functional Role of Phosphodiesterase 3 in Cardiomyocyte Apoptosis: Implication in Heart Failure

  2005cited by this paper
• Role of p90 Ribosomal S6 Kinase (p90RSK) in Reactive Oxygen Species and Protein Kinase C β (PKC-β)-mediated Cardiac Troponin I Phosphorylation*

  2005cited by this paper
• Renin inhibition: what are the therapeutic opportunities?

  2005cited by this paper
• High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells.

  2004cited by this paper
• An update on human and mouse glandular kallikreins.

  2004cited by this paper
• Mechanisms underlying ischemic diastolic dysfunction: relation between rigor, calcium homeostasis, and relaxation rate.

  2003cited by this paper
• Regulation of Epidermal Growth Factor-induced Connexin 43 Gap Junction Communication by Big Mitogen-activated Protein Kinase 1/ERK5 but Not ERK1/2 Kinase Activation*

  2003cited by this paper
• A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

  2003cited by this paper
• Human tissue kallikreins: a family of new cancer biomarkers.

  2002cited by this paper
• Functional Significance of Prorenin Internalization in the Rat Heart

  2002cited by this paper
• Organization and evolution of the glandular kallikrein locus in Mus musculus.

  2002cited by this paper
• Transgenic Overexpression of Constitutively Active Protein Kinase C ε Causes Concentric Cardiac Hypertrophy

  2000cited by this paper
• Pathophysiological role of leptin in obesity-related hypertension.

  2000cited by this paper
• Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy.

  2000cited by this paper
• Reactive Oxygen Species Activate p90 Ribosomal S6 Kinase via Fyn and Ras*

  2000cited by this paper
• The paradox of the low-renin state in diabetic nephropathy.

  1999cited by this paper
• Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction.

  1999cited by this paper
• Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.

  1999cited by this paper
• Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

  1999cited by this paper
• In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts.

  1998cited by this paper
• Cardiomyocyte apoptosis in acute and chronic conditions

  1998cited by this paper
• AT1 receptor blockade in experimental myocardial ischemia/reperfusion

  1998cited by this paper
• Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function.

  1998cited by this paper
• Adrenal Renin-Angiotensin-Aldosterone System in Streptozotocin-Diabetic Rats

  1998cited by this paper
• Heart rate as a determinant of L-type Ca2+ channel activity: Mechanisms and implication in force-frequency relation

  1998cited by this paper
• Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

  1997cited by this paper
• Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta

  1997cited by this paper
• The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro.

  1997cited by this paper
• Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding.

  1997cited by this paper
• Role of the angiotensin II type 1 receptor in preconditioning against infarction

  1997cited by this paper
• The 90-kDa Ribosomal S6 Kinase (pp90rsk) Phosphorylates the N-terminal Regulatory Domain of IκBα and Stimulates Its Degradation in Vitro *

  1997cited by this paper
• Evidence for two catalytically active kinase domains in pp90rsk

  1996cited by this paper
• Biochemical and Molecular Mechanisms in the Development of Diabetic Vascular Complications

  1996cited by this paper
• Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.

  1996cited by this paper
• Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase

  1996cited by this paper
• Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.

  1995cited by this paper
• Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?

  1995cited by this paper
• Reduced Plasma Aldosterone Concentrations in Randomly Selected Patients with Insulin‐dependent Diabetes Mellitus

  1995cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction

  1991cited by this paper
• Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells.

  1991cited by this paper
• The presence of two types of prorenin converting enzymes in the mouse submandibular gland

  1991cited by this paper
• Mouse submandibular gland prorenin-converting enzyme is a member of glandular kallikrein family.

  1991cited by this paper
• Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

  1990cited by this paper
• Prorenin and vascular complications of diabetes.

  1989cited by this paper
• Human neutrophils release serine proteases capable of activating prorenin.

  1987cited by this paper
• Half-life of angiotensin II in the conscious and barbiturate-anaesthetized rat.

  1980cited by this paper
• Activation of inactive plasma renin by tissue kallikreins.

  1979cited by this paper
• The half‐lives of angiotensin II, angiotensin II‐amide, angiotensin III, Sar1‐Ala8‐angiotensin II and renin in the circulatory system of the rat.

  1978cited by this paper
• A "renin-like" enzymatic action of cathepsin D and the similarity in subcellular distributions of "renin-like" activity and cathepsin D in the midbrain of dogs.

  1978cited by this paper

• Angiotensin receptors in GtoPdb v.2025.3

  2025cites this paper
• RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data

  2024cites this paper
• Angiotensin receptors in GtoPdb v.2023.1 Angiotensin receptors in GtoPdb v.2023.1

  2023cites this paper
• Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima

  2023cites this paper
• Disturbed flow-induced FAK K152 SUMOylation initiates the formation of pro-inflammation positive feedback loop by inducing reactive oxygen species production in endothelial cells.

  2021cites this paper
• FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells

  2019cites this paper
• Role of p90RSK in Kidney and Other Diseases

  2019cites this paper
• Senescent Phenotype Induced by p90RSK-NRF2 Signaling Sensitizes Monocytes and Macrophages to Oxidative Stress in HIV-Positive Individuals: Implications for Atherogenesis

  2019cites this paper
• Angiotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy

  2018cites this paper
• Radiation Matters of the Heart: A Mini Review

  2018cites this paper
• Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 Phosphorylation

  2018cites this paper
• Getting to the Heart of the Matter.

  2017cites this paper
• The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury

  2016cites this paper
• Kinase-SUMO networks in diabetes-mediated cardiovascular disease.

  2016cites this paper
• Ribosomal S6 kinase (RSK) modulators: a patent review

  2016cites this paper
• Prorenin and its Receptor: The Role of Direct Renin Inhibition

  2016cites this paper
• RSK3: A regulator of pathological cardiac remodeling

  2015cites this paper
• Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice

  2015cites this paper
• Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.

  2013cites this paper
• Clinical proteomics: getting to the heart of the matter.

  2012cites this paper
• Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury

  2012influential citation
• p90RSK Targets the ERK5-CHIP Ubiquitin E3 Ligase Activity in Diabetic Hearts and Promotes Cardiac Apoptosis and Dysfunction

  2012cites this paper
• p90 ribosomal S6 kinase regulates activity of the renin-angiotensin system: a pathogenic mechanism for ischemia-reperfusion injury.

  2011cites this paper
• La pro-renina y su receptor. Papel de la inhibición directa de la renina

  2011cites this paper
• Novel Role for p90 Ribosomal S6 Kinase in the Regulation of Cardiac Myofilament Phosphorylation*

  2010cites this paper
• Medicinal chemistry of drugs used in diabetic cardiomyopathy.

  2010cites this paper
• Novel Aspects of the Cardiac Renin–Angiotensin System

  2009cites this paper
• Reactive Oxygen Species-Induced Activation of p90 Ribosomal S6 Kinase Prolongs Cardiac Repolarization Through Inhibiting Outward K (cid:1) Channel Activity Cellular Biology

  2008cites this paper
• Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction

  2008cites this paper
• Reactive Oxygen Species-Induced Activation of p90 Ribosomal S6 Kinase Prolongs Cardiac Repolarization Through Inhibiting Outward K+ Channel Activity

  2008cites this paper
• Reactive Oxygen Species-Induced Activation of p90 Ribosomal S6 Kinase Prolongs Cardiac Repolarization Through Inhibiting Outward K (cid:1) Channel Activity Cellular Biology

  2008cites this paper
• High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes.

  2007cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas II.

  2007cites this paper
• Role of PKCs and NF-κB activation in myocardial inflammation: Enemy or ally?

  2007cites this paper
• A clickable inhibitor reveals context-dependent autoactivation of p90 RSK.

  2007cites this paper
• Role of PKCs and NF-kappaB activation in myocardial inflammation: enemy or ally?

  2007cites this paper
• Transcription-based COX-2 inhibition: A therapeutic strategy

  2006cites this paper
• “ Role of p 90 Ribosomal S 6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium ”

  2006cites this paper
• Response to Letter Regarding Article, “Role of p90 Ribosomal S6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemia and Diabetic Myocardium”

  2006cites this paper
• Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".

  2006cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper